Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ergobilt (ERGB) - Ergonomic Chairs -- Ignore unavailable to you. Want to Upgrade?

To: Jim Patterson who wrote (694)	2/23/1998 11:48:00 PM
From: Scott D. Hakala	Read Replies (1) \| Respond to of 900

Jim, I think that you're right on point. I kind of feel the same way about this stock. It would have been nice to see to Company come into value and free up some of my investment by now. I could use some of that value to invest in my own company. As it is, I can't and won't sell this stock at even double the current price unless someone can show me credible evidence that the Company will not perform in the coming fiscal year. The only thing I can add is that the officers and directors are very aware of the issues right now and all of them that I've spoken with still believe that, given a clean year with all of the current operations in place, the stock will be worth substantially more than the market appears to think right now. By the way, ERGB reportedly has filed for a summary judgement on certain issues with NTRL and appears to be confident that it will eventually prevail on the legal issues. There is a published article discussing the history of the dispute between NTRL and BodyBilt and it appears to be mostly pettiness from my perspective on the part of NTRL. Both companies are being hurt by the claims of NTRL. I still can't understand why NTRL has made certain representations in light of the explicit language of a 1991 agreement between NTRL, BodyBilt and Dr. Congleton.